Published in Neurosci Lett on March 28, 2008
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain (2012) 1.22
The primate autoimmune encephalomyelitis model; a bridge between mouse and man. Ann Clin Transl Neurol (2015) 1.00
Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage (2010) 0.97
An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol (2010) 0.97
Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol (2012) 0.94
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study. Neuroimage Clin (2012) 0.91
Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging. Neuroimage (2011) 0.88
Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. Mult Scler (2009) 0.85
Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2013) 0.80
Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult Scler (2010) 0.80
Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol (2016) 0.77
Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29
Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage (2004) 4.13
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol (2001) 4.06
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97
Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol (2003) 2.85
Focal thinning of the cerebral cortex in multiple sclerosis. Brain (2003) 2.74
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci (2006) 1.88
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain (2004) 1.71
Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol (2005) 1.62
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol (2000) 1.60
Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage (2006) 1.40
Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage (2004) 1.12
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage (2004) 1.12
Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain (2005) 0.95
Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am J Pathol (2003) 0.92
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J Neurol Sci (2000) 0.91
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult Scler (2006) 0.90
Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol (2006) 0.90
The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J Neurol Neurosurg Psychiatry (2003) 0.87
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A (2009) 9.19
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol (2007) 5.27
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood (2004) 4.66
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 3.81
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology (2003) 3.72
The role of ipsilateral premotor cortex in hand movement after stroke. Proc Natl Acad Sci U S A (2002) 3.27
Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci (2009) 3.25
Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol (2008) 2.85
Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain (2007) 2.80
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain (2002) 2.57
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab (2011) 2.52
Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci (2003) 2.44
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A (2004) 2.37
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol (2005) 2.29
Neuroscience thinks big (and collaboratively). Nat Rev Neurosci (2013) 2.21
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed (2005) 2.20
Thalamic neurodegeneration in multiple sclerosis. Ann Neurol (2002) 2.20
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 2.17
DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage (2010) 2.10
Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci (2002) 2.10
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed (2005) 2.02
Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med (2010) 2.00
In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab (2002) 1.99
Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg (2004) 1.93
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage (2011) 1.88
Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol (2008) 1.87
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab (2010) 1.85
The role of the posterior fusiform gyrus in reading. J Cogn Neurosci (2006) 1.85
Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res (2005) 1.84
Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol (2005) 1.83
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood (2004) 1.76
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations. J Neurosci (2007) 1.76
New approaches for exploring anatomical and functional connectivity in the human brain. Biol Psychiatry (2004) 1.75
Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry (2002) 1.74
Cellular magnetic resonance imaging: current status and future prospects. Expert Rev Med Devices (2006) 1.71
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage (2010) 1.66
Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry (2007) 1.66
Axonal injury in cerebral malaria. Am J Pathol (2002) 1.65
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology (2012) 1.63
Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage (2008) 1.62
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humans. Cereb Cortex (2005) 1.61
Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells (2005) 1.61
In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther (2004) 1.61
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations. Arch Neurol (2005) 1.60
Variability in fMRI: a re-examination of inter-session differences. Hum Brain Mapp (2005) 1.59
Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed (2006) 1.58
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study. Arch Neurol (2008) 1.56
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 1.55
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med (2012) 1.53
Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia. Cereb Cortex (2002) 1.53
Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis (2011) 1.52
Morphology and the internal structure of words. Proc Natl Acad Sci U S A (2004) 1.52
Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry (2002) 1.52
T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity (2009) 1.50
Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J Neurotrauma (2011) 1.49
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage (2009) 1.48
Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet (2006) 1.47
Functional anatomy of interhemispheric cortical connections in the human brain. J Anat (2006) 1.45
Independent anatomical and functional measures of the V1/V2 boundary in human visual cortex. J Vis (2005) 1.44
Hemispheric specialization for processing auditory nonspeech stimuli. Cereb Cortex (2005) 1.44
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain (2003) 1.43
Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry (2004) 1.42
Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J Neurol Sci (2003) 1.42
In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells (2008) 1.41
Neurite beading is sufficient to decrease the apparent diffusion coefficient after ischemic stroke. Proc Natl Acad Sci U S A (2010) 1.40
Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage (2007) 1.37
Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J (2008) 1.36
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol (2011) 1.32
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr Res (2006) 1.30
Brain activity changes associated with treadmill training after stroke. Stroke (2009) 1.29
Temporal dynamics of the BOLD fMRI impulse response. Neuroimage (2004) 1.28
Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med (2008) 1.28
Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis. Brain (2005) 1.28
Viral capsids as MRI contrast agents. Magn Reson Med (2007) 1.28
Perceiving identical sounds as speech or non-speech modulates activity in the left posterior superior temporal sulcus. Neuroimage (2005) 1.28
Quantitative assessment of the reproducibility of functional activation measured with BOLD and MR perfusion imaging: implications for clinical trial design. Neuroimage (2005) 1.28
Structural and functional bases for individual differences in motor learning. Hum Brain Mapp (2011) 1.27